145 related articles for article (PubMed ID: 25649199)
1. TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states.
Bordelon JR; Grichnik JM
Dermatol Ther; 2015; 28(3):177-8. PubMed ID: 25649199
[No Abstract] [Full Text] [Related]
2. Cancer stem cells and human malignant melanoma.
Schatton T; Frank MH
Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
[TBL] [Abstract][Full Text] [Related]
3. FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytes.
von Willebrand M; Köhler K; Alanko T; Laiho M; Saksela O
Exp Dermatol; 2005 Mar; 14(3):202-8. PubMed ID: 15740593
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta targets PAX3 to control melanocyte differentiation.
Moustakas A
Dev Cell; 2008 Dec; 15(6):797-9. PubMed ID: 19081068
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.
Kong Y; Kumar SM; Xu X
Arch Pathol Lab Med; 2010 Dec; 134(12):1740-9. PubMed ID: 21128770
[TBL] [Abstract][Full Text] [Related]
8. The cell of origin of acral melanomas may be hiding in the sweat glands.
Grichnik JM
Dermatol Ther; 2015; 28(2):105-6. PubMed ID: 25832467
[No Abstract] [Full Text] [Related]
9. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma.
Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
J Invest Dermatol; 2013 May; 133(5):1384-7. PubMed ID: 23389394
[No Abstract] [Full Text] [Related]
10. Epithelial-to-mesenchymal-like transition events in melanoma.
Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretion.
Notsu M; Yamaguchi T; Okazaki K; Tanaka K; Ogawa N; Kanazawa I; Sugimoto T
Endocrinology; 2014 Jul; 155(7):2402-10. PubMed ID: 24758301
[TBL] [Abstract][Full Text] [Related]
13. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
Rodeck U; Nishiyama T; Mauviel A
Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
[TBL] [Abstract][Full Text] [Related]
14. [TGF-β signaling in cancer stem cells].
Naka K
Nihon Rinsho; 2015 May; 73(5):784-9. PubMed ID: 25985631
[TBL] [Abstract][Full Text] [Related]
15. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
16. Stem cells in melanoma development.
Sabatino M; Stroncek DF; Klein H; Marincola FM; Wang E
Cancer Lett; 2009 Jul; 279(2):119-25. PubMed ID: 19095348
[TBL] [Abstract][Full Text] [Related]
17. Differential PAX3 functions in normal skin melanocytes and melanoma cells.
Medic S; Rizos H; Ziman M
Biochem Biophys Res Commun; 2011 Aug; 411(4):832-7. PubMed ID: 21802410
[TBL] [Abstract][Full Text] [Related]
18. Lin28B promotes melanoma growth by mediating a microRNA regulatory circuit.
Zhang Z; Zhang S; Ma P; Jing Y; Peng H; Gao WQ; Zhuang G
Carcinogenesis; 2015 Sep; 36(9):937-45. PubMed ID: 26071398
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.
Cui XY; Skretting G; Jing Y; Sun H; Sandset PM; Sun L
Blood Cells Mol Dis; 2013 Oct; 51(3):177-84. PubMed ID: 23725749
[TBL] [Abstract][Full Text] [Related]
20. TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.
Oshimori N; Oristian D; Fuchs E
Cell; 2015 Feb; 160(5):963-976. PubMed ID: 25723170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]